提示：

1、投稿方式：在线投稿。

2、期刊网址：https://apjai-journal.org/

3、投稿网址：

https://apjai.msubmit.net/cgi-bin/main.plex

4、官网邮箱：

managingeditor@apjai-journal.org（总编）

5、期刊刊期：季刊，逢季末月出版。

2021年8月16日星期一

投稿须知【官网信息】

Author guidelines for APJAI

(effective as of Aug6, 2021)

Please submit your manuscript via online submission system at the following address: http://www.apjai-journal.org.

Mission Statement

The Asian Pacific Journal of Allergy and Immunology (APJAI) publishes original research articles, clinical observations, case reports and reviews on various aspects of allergy and immunology provided that they have not been, and will not be, published elsewhere in whole, or in part, without the Editor’s permission. Papers accepted become the copyright of the Journal. Authors are responsible for all statements in articles submitted to the APJAI.

Journal Publication Policies and Procedures

The APJAI will consider for publication those papers directly related to allergy and immunology and has agreed to follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (the “Uniform Requirements”) of the International Committee of Medical Journal Editors (ICMJE), the full text of which is available at http://www.icmje.org. The manuscript submission instructions for the APJAI submission are consistent with the 2009 version of the Uniform Requirements. The Editor assumes that upon submission of a manuscript, all listed authors have agreed with the APJAI policies. Manuscripts that do not meet these guidelines will be returned to the submitting author for revision prior to any further consideration for peer review.

Submissions will be considered for publication in APJAI only if they are submitted solely to APJAI. It must not have been previously published and must not be under consideration for publication elsewhere. All published manuscripts become the permanent property of the APJAI and may not be published elsewhere without written permission.

Ethical Approval of Studies and Informed Consent

For all research studies involving human subjects or research material derived from humans, a statement describing approval by the appropriate Institutional Review Board (IRB) is required in the Methods Section. Authors must declare how and if the informed consents were obtained from the study participants, if the study is conducted in humans, in the Methods Section. Studies exempted from IRB approval by their respective boards should be indicated in the Methods Section. Institutional Review Board approval and informed consent statements are not required for Case Reports. Studies involving experimental animals must include a statement in the Methods Section indicating that institutional or national guidelines were followed for the care and use of the animals. Failure to comply with this requirement will result in the manuscript being returned without review.

Clinical Trial Registration

APJAI requires investigators to preregister their clinical trials in a public trial registry approved by WHO (http://www.who.int/ictrp/network/primary/en/).

APJAI has adopted the WHO’s definition of a clinical trial: “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.” The clinical trial registration number and name of the registry should be clearly identified on the title page and in the Methods Section.

Manuscript Preparation and Submission Requirements

The authors must submit the cover letter, title page, abstract, manuscript text, tables, figures, and/or supplement files. Please read the instruction in the online submission system carefully as many changes have been implemented. All manuscripts are subjected to open peer-review.

……

更多详情：

https://apjai-journal.org/wp-content/uploads/2021/08/Author-Guidelines-2021-Aug.pdf